APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Plasminogen Activator Inhibitor 1

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Plasminogen Activator Inhibitor 1 Industry Growth and Trends Forecast to 2032

Report ID 174026570119 December 202578 pages

Choose your research edition.

Industry ResearchPlasminogen Activator Inhibitor 1 Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Plasminogen Activator Inhibitor 1 Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Plasminogen Activator Inhibitor 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plasminogen Activator Inhibitor 1 Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Plasminogen Activator Inhibitor 1 Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Plasminogen Activator Inhibitor 1 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Plasminogen Activator Inhibitor 1 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Plasminogen Activator Inhibitor 1 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Plasminogen Activator Inhibitor 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Plasminogen Activator Inhibitor 1 include D-Pharm Ltd and Jazz Pharmaceuticals Plc among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Plasminogen Activator Inhibitor 1 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Plasminogen Activator Inhibitor 1 market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Plasminogen Activator Inhibitor 1 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Plasminogen Activator Inhibitor 1.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Plasminogen Activator Inhibitor 1 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Plasminogen Activator Inhibitor 1 Market by Company

D-Pharm Ltd

Jazz Pharmaceuticals Plc

Plasminogen Activator Inhibitor 1 Segment by Type

CT-140

SK-216

THR-18

Defibrotide Sodium

Others

Plasminogen Activator Inhibitor 1 Segment by Application

Thrombosis

Acute Ischemic Stroke

Hypertension

Arterial Thrombosis

Others

Plasminogen Activator Inhibitor 1 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasminogen Activator Inhibitor 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plasminogen Activator Inhibitor 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasminogen Activator Inhibitor 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Plasminogen Activator Inhibitor 1 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Plasminogen Activator Inhibitor 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of CT-140 Table 2. Major Company of SK-216 Table 3. Major Company of THR-18 Table 4. Major Company of Defibrotide Sodium Table 5. Major Company of Others Table 6. Global Plasminogen Activator Inhibitor 1 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Plasminogen Activator Inhibitor 1 Sales by Type (2021-2026) & (K Units) Table 8. Global Plasminogen Activator Inhibitor 1 Sales Market Share in Volume by Type (2021-2026) Table 9. Global Plasminogen Activator Inhibitor 1 Sales by Type (2021-2026) & (US$ Million) Table 10. Global Plasminogen Activator Inhibitor 1 Sales Market Share in Value by Type (2021-2026) Table 11. Global Plasminogen Activator Inhibitor 1 Price by Type (2021-2026) & (US$/Unit) Table 12. Global Plasminogen Activator Inhibitor 1 Sales by Type (2027-2032) & (K Units) Table 13. Global Plasminogen Activator Inhibitor 1 Sales Market Share in Volume by Type (2027-2032) Table 14. Global Plasminogen Activator Inhibitor 1 Sales by Type (2027-2032) & (US$ Million) Table 15. Global Plasminogen Activator Inhibitor 1 Sales Market Share in Value by Type (2027-2032) Table 16. Global Plasminogen Activator Inhibitor 1 Price by Type (2027-2032) & (US$/Unit) Table 17. North America Plasminogen Activator Inhibitor 1 Sales by Type (2021-2026) & (K Units) Table 18. North America Plasminogen Activator Inhibitor 1 Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Plasminogen Activator Inhibitor 1 Sales by Type (2021-2026) & (K Units) Table 20. Europe Plasminogen Activator Inhibitor 1 Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Plasminogen Activator Inhibitor 1 Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Plasminogen Activator Inhibitor 1 Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Plasminogen Activator Inhibitor 1 Sales by Type (2021-2026) & (K Units) Table 24. Latin America Plasminogen Activator Inhibitor 1 Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Plasminogen Activator Inhibitor 1 Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Plasminogen Activator Inhibitor 1 Sales by Type (2021-2026) & (US$ Million) Table 27. Plasminogen Activator Inhibitor 1 Industry Trends Table 28. Plasminogen Activator Inhibitor 1 Industry Drivers Table 29. Plasminogen Activator Inhibitor 1 Industry Opportunities and Challenges Table 30. Plasminogen Activator Inhibitor 1 Industry Restraints Table 31. Global Plasminogen Activator Inhibitor 1 Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Plasminogen Activator Inhibitor 1 Revenue Market Share by Company (2021-2026) Table 33. Global Plasminogen Activator Inhibitor 1 Sales by Company (2021-2026) & (K Units) Table 34. Global Plasminogen Activator Inhibitor 1 Sales Share by Company (2021-2026) Table 35. Global Plasminogen Activator Inhibitor 1 Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Plasminogen Activator Inhibitor 1 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Plasminogen Activator Inhibitor 1 Major Company Production Sites and Headquarters Table 38. Global Plasminogen Activator Inhibitor 1 Company, Product Type & Application Table 39. Global Plasminogen Activator Inhibitor 1 Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Plasminogen Activator Inhibitor 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Plasminogen Activator Inhibitor 1 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Plasminogen Activator Inhibitor 1 Sales by Region (2021-2026) & (K Units) Table 44. Global Plasminogen Activator Inhibitor 1 Sales Market Share in Volume by Region (2021-2026) Table 45. Global Plasminogen Activator Inhibitor 1 Sales by Region (2021-2026) & (US$ Million) Table 46. Global Plasminogen Activator Inhibitor 1 Sales Market Share in Value by Region (2021-2026) Table 47. Global Plasminogen Activator Inhibitor 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Plasminogen Activator Inhibitor 1 Sales by Region (2027-2032) & (K Units) Table 49. Global Plasminogen Activator Inhibitor 1 Sales Market Share in Volume by Region (2027-2032) Table 50. Global Plasminogen Activator Inhibitor 1 Sales by Region (2027-2032) & (US$ Million) Table 51. Global Plasminogen Activator Inhibitor 1 Sales Market Share in Value by Region (2027-2032) Table 52. Global Plasminogen Activator Inhibitor 1 Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Plasminogen Activator Inhibitor 1 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Plasminogen Activator Inhibitor 1 Sales by Application (2021-2026) & (K Units) Table 55. Global Plasminogen Activator Inhibitor 1 Sales Market Share in Volume by Application (2021-2026) Table 56. Global Plasminogen Activator Inhibitor 1 Sales by Application (2021-2026) & (US$ Million) Table 57. Global Plasminogen Activator Inhibitor 1 Sales Market Share in Value by Application (2021-2026) Table 58. Global Plasminogen Activator Inhibitor 1 Price by Application (2021-2026) & (US$/Unit) Table 59. Global Plasminogen Activator Inhibitor 1 Sales by Application (2027-2032) & (K Units) Table 60. Global Plasminogen Activator Inhibitor 1 Sales Market Share in Volume by Application (2027-2032) Table 61. Global Plasminogen Activator Inhibitor 1 Sales by Application (2027-2032) & (US$ Million) Table 62. Global Plasminogen Activator Inhibitor 1 Sales Market Share in Value by Application (2027-2032) Table 63. Global Plasminogen Activator Inhibitor 1 Price by Application (2027-2032) & (US$/Unit) Table 64. North America Plasminogen Activator Inhibitor 1 Sales by Application (2021-2026) & (K Units) Table 65. North America Plasminogen Activator Inhibitor 1 Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Plasminogen Activator Inhibitor 1 Sales by Application (2021-2026) & (K Units) Table 67. Europe Plasminogen Activator Inhibitor 1 Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Plasminogen Activator Inhibitor 1 Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Plasminogen Activator Inhibitor 1 Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Plasminogen Activator Inhibitor 1 Sales by Application (2021-2026) & (K Units) Table 71. Latin America Plasminogen Activator Inhibitor 1 Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Plasminogen Activator Inhibitor 1 Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Plasminogen Activator Inhibitor 1 Sales by Application (2021-2026) & (US$ Million) Table 74. D-Pharm Ltd Company Information Table 75. D-Pharm Ltd Business Overview Table 76. D-Pharm Ltd Plasminogen Activator Inhibitor 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. D-Pharm Ltd Plasminogen Activator Inhibitor 1 Product Portfolio Table 78. D-Pharm Ltd Recent Development Table 79. Jazz Pharmaceuticals Plc Company Information Table 80. Jazz Pharmaceuticals Plc Business Overview Table 81. Jazz Pharmaceuticals Plc Plasminogen Activator Inhibitor 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Jazz Pharmaceuticals Plc Plasminogen Activator Inhibitor 1 Product Portfolio Table 83. Jazz Pharmaceuticals Plc Recent Development Table 84. North America Plasminogen Activator Inhibitor 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 85. North America Plasminogen Activator Inhibitor 1 Sales by Country (2021-2026) & (K Units) Table 86. North America Plasminogen Activator Inhibitor 1 Sales Market Share by Country (2021-2026) Table 87. North America Plasminogen Activator Inhibitor 1 Sales Forecast by Country (2027-2032) & (K Units) Table 88. North America Plasminogen Activator Inhibitor 1 Sales Market Share Forecast by Country (2027-2032) Table 89. North America Plasminogen Activator Inhibitor 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 90. North America Plasminogen Activator Inhibitor 1 Market Size by Country (2021-2026) & (US$ Million) Table 91. North America Plasminogen Activator Inhibitor 1 Market Share by Country (2021-2026) Table 92. North America Plasminogen Activator Inhibitor 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 93. North America Plasminogen Activator Inhibitor 1 Market Share Forecast by Country (2027-2032) Table 94. Europe Plasminogen Activator Inhibitor 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 95. Europe Plasminogen Activator Inhibitor 1 Sales by Country (2021-2026) & (K Units) Table 96. Europe Plasminogen Activator Inhibitor 1 Sales Market Share by Country (2021-2026) Table 97. Europe Plasminogen Activator Inhibitor 1 Sales Forecast by Country (2027-2032) & (K Units) Table 98. Europe Plasminogen Activator Inhibitor 1 Sales Market Share Forecast by Country (2027-2032) Table 99. Europe Plasminogen Activator Inhibitor 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 100. Europe Plasminogen Activator Inhibitor 1 Market Size by Country (2021-2026) & (US$ Million) Table 101. Europe Plasminogen Activator Inhibitor 1 Market Share by Country (2021-2026) Table 102. Europe Plasminogen Activator Inhibitor 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 103. Europe Plasminogen Activator Inhibitor 1 Market Share Forecast by Country (2027-2032) Table 104. Asia-Pacific Plasminogen Activator Inhibitor 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 105. Asia-Pacific Plasminogen Activator Inhibitor 1 Sales by Country (2021-2026) & (K Units) Table 106. Asia-Pacific Plasminogen Activator Inhibitor 1 Sales Market Share by Country (2021-2026) Table 107. Asia-Pacific Plasminogen Activator Inhibitor 1 Sales Forecast by Country (2027-2032) & (K Units) Table 108. Asia-Pacific Plasminogen Activator Inhibitor 1 Sales Market Share Forecast by Country (2027-2032) Table 109. Asia-Pacific Plasminogen Activator Inhibitor 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 110. Asia-Pacific Plasminogen Activator Inhibitor 1 Market Size by Country (2021-2026) & (US$ Million) Table 111. Asia-Pacific Plasminogen Activator Inhibitor 1 Market Share by Country (2021-2026) Table 112. Asia-Pacific Plasminogen Activator Inhibitor 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 113. Asia-Pacific Plasminogen Activator Inhibitor 1 Market Share Forecast by Country (2027-2032) Table 114. Latin America Plasminogen Activator Inhibitor 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 115. Latin America Plasminogen Activator Inhibitor 1 Sales by Country (2021-2026) & (K Units) Table 116. Latin America Plasminogen Activator Inhibitor 1 Sales Market Share by Country (2021-2026) Table 117. Latin America Plasminogen Activator Inhibitor 1 Sales Forecast by Country (2027-2032) & (K Units) Table 118. Latin America Plasminogen Activator Inhibitor 1 Sales Market Share Forecast by Country (2027-2032) Table 119. Latin America Plasminogen Activator Inhibitor 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. Latin America Plasminogen Activator Inhibitor 1 Market Size by Country (2021-2026) & (US$ Million) Table 121. Latin America Plasminogen Activator Inhibitor 1 Market Share by Country (2021-2026) Table 122. Latin America Plasminogen Activator Inhibitor 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. Latin America Plasminogen Activator Inhibitor 1 Market Share Forecast by Country (2027-2032) Table 124. Middle East and Africa Plasminogen Activator Inhibitor 1 Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 125. Middle East and Africa Plasminogen Activator Inhibitor 1 Sales by Country (2021-2026) & (K Units) Table 126. Middle East and Africa Plasminogen Activator Inhibitor 1 Sales Market Share by Country (2021-2026) Table 127. Middle East and Africa Plasminogen Activator Inhibitor 1 Sales Forecast by Country (2027-2032) & (K Units) Table 128. Middle East and Africa Plasminogen Activator Inhibitor 1 Sales Market Share Forecast by Country (2027-2032) Table 129. Middle East and Africa Plasminogen Activator Inhibitor 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Middle East and Africa Plasminogen Activator Inhibitor 1 Market Size by Country (2021-2026) & (US$ Million) Table 131. Middle East and Africa Plasminogen Activator Inhibitor 1 Market Share by Country (2021-2026) Table 132. Middle East and Africa Plasminogen Activator Inhibitor 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Middle East and Africa Plasminogen Activator Inhibitor 1 Market Share Forecast by Country (2027-2032) Table 134. Key Raw Materials Table 135. Raw Materials Key Suppliers Table 136. Plasminogen Activator Inhibitor 1 Distributors List Table 137. Plasminogen Activator Inhibitor 1 Customers List Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Plasminogen Activator Inhibitor 1 Image Figure 2. Global Plasminogen Activator Inhibitor 1 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plasminogen Activator Inhibitor 1 Market Size (2021-2032) & (US$ Million) Figure 4. Global Plasminogen Activator Inhibitor 1 Sales (2021-2032) & (K Units) Figure 5. CT-140 Image Figure 6. Global CT-140 Sales YoY Growth (2021-2032) & (K Units) Figure 7. SK-216 Image Figure 8. Global SK-216 Sales YoY Growth (2021-2032) & (K Units) Figure 9. THR-18 Image Figure 10. Global THR-18 Sales YoY Growth (2021-2032) & (K Units) Figure 11. Defibrotide Sodium Image Figure 12. Global Defibrotide Sodium Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Plasminogen Activator Inhibitor 1 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Plasminogen Activator Inhibitor 1 Market Share by Type 2025 VS 2032 Figure 17. North America Plasminogen Activator Inhibitor 1 Sales Market Share in Volume by Type in 2025 Figure 18. North America Plasminogen Activator Inhibitor 1 Sales Market Share in Value by Type in 2025 Figure 19. Europe Plasminogen Activator Inhibitor 1 Sales Market Share in Volume by Type in 2025 Figure 20. Europe Plasminogen Activator Inhibitor 1 Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Plasminogen Activator Inhibitor 1 Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Plasminogen Activator Inhibitor 1 Sales Market Share in Value by Type in 2025 Figure 23. Latin America Plasminogen Activator Inhibitor 1 Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Plasminogen Activator Inhibitor 1 Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Plasminogen Activator Inhibitor 1 Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Plasminogen Activator Inhibitor 1 Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Plasminogen Activator Inhibitor 1 Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Thrombosis Image Figure 30. Global Thrombosis Sales YoY Growth (2021-2032) & (K Units) Figure 31. Acute Ischemic Stroke Image Figure 32. Global Acute Ischemic Stroke Sales YoY Growth (2021-2032) & (K Units) Figure 33. Hypertension Image Figure 34. Global Hypertension Sales YoY Growth (2021-2032) & (K Units) Figure 35. Arterial Thrombosis Image Figure 36. Global Arterial Thrombosis Sales YoY Growth (2021-2032) & (K Units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global Plasminogen Activator Inhibitor 1 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Plasminogen Activator Inhibitor 1 Market Share by Application 2025 VS 2032 Figure 41. North America Plasminogen Activator Inhibitor 1 Sales Market Share in Volume by Application in 2025 Figure 42. North America Plasminogen Activator Inhibitor 1 Sales Market Share in Value by Application in 2025 Figure 43. Europe Plasminogen Activator Inhibitor 1 Sales Market Share in Volume by Application in 2025 Figure 44. Europe Plasminogen Activator Inhibitor 1 Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Plasminogen Activator Inhibitor 1 Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Plasminogen Activator Inhibitor 1 Sales Market Share in Value by Application in 2025 Figure 47. Latin America Plasminogen Activator Inhibitor 1 Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Plasminogen Activator Inhibitor 1 Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Plasminogen Activator Inhibitor 1 Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Plasminogen Activator Inhibitor 1 Sales Market Share in Value by Application in 2025 Figure 51. North America Plasminogen Activator Inhibitor 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America Plasminogen Activator Inhibitor 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Plasminogen Activator Inhibitor 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Plasminogen Activator Inhibitor 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Plasminogen Activator Inhibitor 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe Plasminogen Activator Inhibitor 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Plasminogen Activator Inhibitor 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Plasminogen Activator Inhibitor 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Plasminogen Activator Inhibitor 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific Plasminogen Activator Inhibitor 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Plasminogen Activator Inhibitor 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Plasminogen Activator Inhibitor 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Plasminogen Activator Inhibitor 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America Plasminogen Activator Inhibitor 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Plasminogen Activator Inhibitor 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Plasminogen Activator Inhibitor 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Plasminogen Activator Inhibitor 1 Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa Plasminogen Activator Inhibitor 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Plasminogen Activator Inhibitor 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Plasminogen Activator Inhibitor 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Plasminogen Activator Inhibitor 1 Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Plasminogen Activator Inhibitor 1 Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • CT-140
  • SK-216
  • THR-18
  • Defibrotide Sodium
  • Others
Applications
  • Thrombosis
  • Acute Ischemic Stroke
  • Hypertension
  • Arterial Thrombosis
  • Others
Companies covered
  • D-Pharm Ltd
  • Jazz Pharmaceuticals Plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Plasminogen Activator Inhibitor 1 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Plasminogen Activator Inhibitor 1 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Plasminogen Activator Inhibitor 1 Market by Type
  6. 1.3.1 CT-140
  7. 1.3.2 SK-216
  8. 1.3.3 THR-18
  9. 1.3.4 Defibrotide Sodium
  10. 1.3.5 Others
  11. 1.4 Global Plasminogen Activator Inhibitor 1 Market Size by Type
  12. 1.4.1 Global Plasminogen Activator Inhibitor 1 Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Plasminogen Activator Inhibitor 1 Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Plasminogen Activator Inhibitor 1 Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Plasminogen Activator Inhibitor 1 Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Plasminogen Activator Inhibitor 1 Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Plasminogen Activator Inhibitor 1 Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Plasminogen Activator Inhibitor 1 Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Plasminogen Activator Inhibitor 1 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Plasminogen Activator Inhibitor 1 Industry Trends
  2. 2.2 Plasminogen Activator Inhibitor 1 Industry Drivers
  3. 2.3 Plasminogen Activator Inhibitor 1 Industry Opportunities and Challenges
  4. 2.4 Plasminogen Activator Inhibitor 1 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Plasminogen Activator Inhibitor 1 Revenue (2021-2026)
  2. 3.2 Global Top Players by Plasminogen Activator Inhibitor 1 Sales (2021-2026)
  3. 3.3 Global Top Players by Plasminogen Activator Inhibitor 1 Price (2021-2026)
  4. 3.4 Global Plasminogen Activator Inhibitor 1 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Plasminogen Activator Inhibitor 1 Major Company Production Sites & Headquarters
  6. 3.6 Global Plasminogen Activator Inhibitor 1 Company, Product Type & Application
  7. 3.7 Global Plasminogen Activator Inhibitor 1 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Plasminogen Activator Inhibitor 1 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Plasminogen Activator Inhibitor 1 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Plasminogen Activator Inhibitor 1 Tier 1, Tier 2, and Tier 3
4 Plasminogen Activator Inhibitor 1 Regional Status and Outlook
  1. 4.1 Global Plasminogen Activator Inhibitor 1 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Plasminogen Activator Inhibitor 1 Historic Market Size by Region
  3. 4.2.1 Global Plasminogen Activator Inhibitor 1 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Plasminogen Activator Inhibitor 1 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Plasminogen Activator Inhibitor 1 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Plasminogen Activator Inhibitor 1 Forecasted Market Size by Region
  7. 4.3.1 Global Plasminogen Activator Inhibitor 1 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Plasminogen Activator Inhibitor 1 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Plasminogen Activator Inhibitor 1 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Plasminogen Activator Inhibitor 1 by Application
  1. 5.1 Plasminogen Activator Inhibitor 1 Market by Application
  2. 5.1.1 Thrombosis
  3. 5.1.2 Acute Ischemic Stroke
  4. 5.1.3 Hypertension
  5. 5.1.4 Arterial Thrombosis
  6. 5.1.5 Others
  7. 5.2 Global Plasminogen Activator Inhibitor 1 Market Size by Application
  8. 5.2.1 Global Plasminogen Activator Inhibitor 1 Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Plasminogen Activator Inhibitor 1 Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Plasminogen Activator Inhibitor 1 Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Plasminogen Activator Inhibitor 1 Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Plasminogen Activator Inhibitor 1 Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Plasminogen Activator Inhibitor 1 Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Plasminogen Activator Inhibitor 1 Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Plasminogen Activator Inhibitor 1 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 D-Pharm Ltd
  2. 6.1.1 D-Pharm Ltd Company Information
  3. 6.1.2 D-Pharm Ltd Business Overview
  4. 6.1.3 D-Pharm Ltd Plasminogen Activator Inhibitor 1 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 D-Pharm Ltd Plasminogen Activator Inhibitor 1 Product Portfolio
  6. 6.1.5 D-Pharm Ltd Recent Developments
  7. 6.2 Jazz Pharmaceuticals Plc
  8. 6.2.1 Jazz Pharmaceuticals Plc Company Information
  9. 6.2.2 Jazz Pharmaceuticals Plc Business Overview
  10. 6.2.3 Jazz Pharmaceuticals Plc Plasminogen Activator Inhibitor 1 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Jazz Pharmaceuticals Plc Plasminogen Activator Inhibitor 1 Product Portfolio
  12. 6.2.5 Jazz Pharmaceuticals Plc Recent Developments
7 North America by Country
  1. 7.1 North America Plasminogen Activator Inhibitor 1 Sales by Country
  2. 7.1.1 North America Plasminogen Activator Inhibitor 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Plasminogen Activator Inhibitor 1 Sales by Country (2021-2026)
  4. 7.1.3 North America Plasminogen Activator Inhibitor 1 Sales Forecast by Country (2027-2032)
  5. 7.2 North America Plasminogen Activator Inhibitor 1 Market Size by Country
  6. 7.2.1 North America Plasminogen Activator Inhibitor 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Plasminogen Activator Inhibitor 1 Market Size by Country (2021-2026)
  8. 7.2.3 North America Plasminogen Activator Inhibitor 1 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Plasminogen Activator Inhibitor 1 Sales by Country
  2. 8.1.1 Europe Plasminogen Activator Inhibitor 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Plasminogen Activator Inhibitor 1 Sales by Country (2021-2026)
  4. 8.1.3 Europe Plasminogen Activator Inhibitor 1 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Plasminogen Activator Inhibitor 1 Market Size by Country
  6. 8.2.1 Europe Plasminogen Activator Inhibitor 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Plasminogen Activator Inhibitor 1 Market Size by Country (2021-2026)
  8. 8.2.3 Europe Plasminogen Activator Inhibitor 1 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Plasminogen Activator Inhibitor 1 Sales by Country
  2. 9.1.1 Asia-Pacific Plasminogen Activator Inhibitor 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Plasminogen Activator Inhibitor 1 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Plasminogen Activator Inhibitor 1 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Plasminogen Activator Inhibitor 1 Market Size by Country
  6. 9.2.1 Asia-Pacific Plasminogen Activator Inhibitor 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Plasminogen Activator Inhibitor 1 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Plasminogen Activator Inhibitor 1 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Plasminogen Activator Inhibitor 1 Sales by Country
  2. 10.1.1 South America Plasminogen Activator Inhibitor 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Plasminogen Activator Inhibitor 1 Sales by Country (2021-2026)
  4. 10.1.3 South America Plasminogen Activator Inhibitor 1 Sales Forecast by Country (2027-2032)
  5. 10.2 South America Plasminogen Activator Inhibitor 1 Market Size by Country
  6. 10.2.1 South America Plasminogen Activator Inhibitor 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Plasminogen Activator Inhibitor 1 Market Size by Country (2021-2026)
  8. 10.2.3 South America Plasminogen Activator Inhibitor 1 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Plasminogen Activator Inhibitor 1 Sales by Country
  2. 11.1.1 Middle East and Africa Plasminogen Activator Inhibitor 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Plasminogen Activator Inhibitor 1 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Plasminogen Activator Inhibitor 1 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Plasminogen Activator Inhibitor 1 Market Size by Country
  6. 11.2.1 Middle East and Africa Plasminogen Activator Inhibitor 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Plasminogen Activator Inhibitor 1 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Plasminogen Activator Inhibitor 1 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Plasminogen Activator Inhibitor 1 Value Chain Analysis
  2. 12.1.1 Plasminogen Activator Inhibitor 1 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Plasminogen Activator Inhibitor 1 Production Mode & Process
  7. 12.2 Plasminogen Activator Inhibitor 1 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Plasminogen Activator Inhibitor 1 Distributors
  10. 12.2.3 Plasminogen Activator Inhibitor 1 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst